Lepu Medical Technology (Beijing) Co., Ltd. (SHE: 300003)
China
· Delayed Price · Currency is CNY
10.98
+0.14 (1.29%)
Jan 6, 2025, 3:04 PM CST
Lepu Medical Technology (Beijing) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 707.26 | 1,258 | 2,204 | 1,719 | 1,802 | 1,725 | Upgrade
|
Depreciation & Amortization | 513.56 | 513.56 | 488.47 | 448.74 | 388.21 | 284.49 | Upgrade
|
Other Amortization | 90.22 | 90.22 | 79.16 | 72.83 | 54.92 | 40.57 | Upgrade
|
Loss (Gain) From Sale of Assets | 7.87 | 7.87 | 1.69 | -19.9 | -2.29 | -4.12 | Upgrade
|
Asset Writedown & Restructuring Costs | 36.59 | 36.59 | - | 2.39 | -434.02 | 268.14 | Upgrade
|
Loss (Gain) From Sale of Investments | 13.44 | 13.44 | 70.91 | 367.54 | 153.17 | -412.43 | Upgrade
|
Provision & Write-off of Bad Debts | 26.13 | 26.13 | 24.45 | 20.76 | 38.17 | 38.57 | Upgrade
|
Other Operating Activities | 707.26 | 337.04 | 278.83 | 308.15 | 349.86 | 449.78 | Upgrade
|
Change in Accounts Receivable | 3.22 | 3.22 | -665.07 | 42.85 | -32.72 | -252.5 | Upgrade
|
Change in Inventory | -251.01 | -251.01 | -386.7 | -494.73 | -422.85 | -205.59 | Upgrade
|
Change in Accounts Payable | -982 | -982 | 710.12 | 660.39 | 165.53 | 78.15 | Upgrade
|
Operating Cash Flow | 809.63 | 990.36 | 2,791 | 3,062 | 2,090 | 1,990 | Upgrade
|
Operating Cash Flow Growth | -48.52% | -64.51% | -8.86% | 46.53% | 5.00% | 32.64% | Upgrade
|
Capital Expenditures | -650.66 | -844.67 | -905.22 | -984.4 | -600.15 | -563.11 | Upgrade
|
Sale of Property, Plant & Equipment | 32.09 | 8.52 | 2.55 | 2.09 | 44.66 | 6.99 | Upgrade
|
Cash Acquisitions | -141.42 | -344.92 | -3.1 | -453.01 | -112.94 | -240.9 | Upgrade
|
Divestitures | -32.83 | -48.08 | - | 0.15 | 3.25 | - | Upgrade
|
Investment in Securities | -324.25 | -65.41 | -648.89 | 129.18 | 17.77 | 53.48 | Upgrade
|
Other Investing Activities | -511.56 | -428.32 | 0.47 | 533.27 | -210.35 | 225.58 | Upgrade
|
Investing Cash Flow | -1,792 | -1,886 | -1,599 | -860.46 | -695.45 | -651.22 | Upgrade
|
Long-Term Debt Issued | - | 2,694 | 1,828 | 3,745 | 4,699 | 3,586 | Upgrade
|
Long-Term Debt Repaid | - | -2,320 | -2,601 | -4,338 | -4,798 | -4,123 | Upgrade
|
Total Debt Repaid | -2,360 | -2,320 | -2,601 | -4,338 | -4,798 | -4,123 | Upgrade
|
Net Debt Issued (Repaid) | 891.08 | 373.41 | -772.86 | -592.54 | -98.91 | -537.29 | Upgrade
|
Issuance of Common Stock | - | - | 1,533 | - | - | - | Upgrade
|
Repurchase of Common Stock | -75.24 | -75.24 | -245.91 | -109.91 | - | - | Upgrade
|
Common Dividends Paid | -983.09 | -768.66 | -635.65 | -587.04 | -598.4 | -639.18 | Upgrade
|
Other Financing Activities | -236.65 | 177.57 | 534.17 | 392.09 | -66.12 | -372.37 | Upgrade
|
Financing Cash Flow | -403.9 | -292.92 | 412.75 | -897.41 | -763.44 | -1,549 | Upgrade
|
Foreign Exchange Rate Adjustments | -3.22 | -20.59 | 21.13 | -11.31 | -31.23 | 4.39 | Upgrade
|
Net Cash Flow | -1,389 | -1,209 | 1,625 | 1,293 | 599.58 | -205.42 | Upgrade
|
Free Cash Flow | 158.97 | 145.69 | 1,885 | 2,078 | 1,490 | 1,427 | Upgrade
|
Free Cash Flow Growth | -75.24% | -92.27% | -9.25% | 39.48% | 4.37% | 233.00% | Upgrade
|
Free Cash Flow Margin | 2.44% | 1.83% | 17.77% | 19.49% | 18.53% | 18.31% | Upgrade
|
Free Cash Flow Per Share | 0.09 | 0.08 | 1.04 | 1.15 | 0.84 | 0.81 | Upgrade
|
Cash Income Tax Paid | 874.09 | 970.56 | 962.96 | 725.21 | 831.87 | 984.18 | Upgrade
|
Levered Free Cash Flow | 140.06 | -169.88 | 1,603 | 1,479 | 848.37 | 573.22 | Upgrade
|
Unlevered Free Cash Flow | 249.02 | -63.22 | 1,721 | 1,622 | 1,016 | 774.29 | Upgrade
|
Change in Net Working Capital | 465.69 | 986.63 | -229.14 | -452.66 | 123.79 | 360.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.